01/02/2026
Budget 2026-27 is clearly investment-led. The biggest highlight is capital expenditure of about ₹12.2 lakh crore, nearly 11% higher than last year, aimed at infrastructure and job creation. Railways, highways, and logistics corridors remain top priorities, along with high-speed rail and rare-earth supply chains to reduce import dependence.
The government also announced Semiconductor Mission 2.0 with fresh incentives, while the BioPharma Shakti program gets around ₹10,000 crore to strengthen India’s pharma manufacturing ecosystem. On the tax front, lower TCS rates on foreign travel and education and rationalisation of corporate taxes aim to boost consumption and investment. Despite higher spending, the fiscal deficit is kept around 4.3–4.4% of GDP, showing continued fiscal discipline.
Pluses:
Strong capex of ₹12+ lakh crore supports long-term growth, manufacturing and technology sectors get targeted funding, strategic industries like semiconductors and biotech gain policy support, and controlled deficit improves investor confidence.
Drawbacks:
Private sector capex remains cautious, and spending on health and education grows slower compared to infrastructure.
Overall, Budget 26-27 is bold, growth-focused, and future-oriented , but delivery will decide results.
